APOE and Alzheimer disease: Additionally, activating lipid‐sensitive nuclear receptors, including retinoid X receptors (RXRs),[158] LXRs, and PPARs,[159] inhibiting de novo synthesis of FAs in the brain, promoting lipid transport proteins (APOE and ABCA1), and administering cholesterol‐lowering drugs are also important strategies for treating AD.[160]